Ma Y - Search Results

1

Resveratrol as a potential therapeutic agent for sarcopenic obesity: Insights from in vivoperiments.

Long Y, Wu Y, Zhong Y, Wu Y, Ye H, Luo Y, Xiao L, Ma Y, Wang M. Long Y, et al. Among authors: ma y. Biomed Pharmacother. 2024 Oct;179:117396. doi: 10.1016/j.biopha.2024.117396. Epub 2024 Sep 4. Biomed Pharmacother. 2024. PMID: 39236475 Free article.

2

Potential bioactive compounds and mechanisms of Fibraurea recisa Pierre for the treatment of Alzheimer's disease analyzed by network pharmacology and molecular docking prediction.

Wang S, Ma Y, Huang Y, Hu Y, Huang Y, Wu Y. Wang S, et al. Among authors: ma y. Front Aging Neurosci. 2022 Dec 8;14:1052249. doi: 10.3389/fnagi.2022.1052249. eCollection 2022. Front Aging Neurosci. 2022. PMID: 36570530 Free PMC article.

3

Synthesis, radiolabeling, and evaluation of 68Ga-labeled aminoquinoxaline derivative as a potent PFKFB3-targeted PET tracer.

Chen F, Wu Y, Ma Y, Yin H, Su F, Huang R, Wu X, Liu Q. Chen F, et al. Among authors: ma y. Front Chem. 2023 Mar 22;11:1158503. doi: 10.3389/fchem.2023.1158503. eCollection 2023. Front Chem. 2023. PMID: 37035116 Free PMC article.

4

Feasibility study on the use of "Qi-tonifying medicine compound" as an anti-fatigue functional food ingredient based on network pharmacology and molecular docking.

Wu Y, Ma Y, Cao J, Xie R, Chen F, Hu W, Huang Y. Wu Y, et al. Among authors: ma y. Front Nutr. 2023 May 5;10:1131972. doi: 10.3389/fnut.2023.1131972. eCollection 2023. Front Nutr. 2023. PMID: 37215213 Free PMC article.

5

Network pharmacology‒based analysis of marine cyanobacteria derived bioactive compounds for application to Alzheimer's disease.

Xie R, Chen F, Ma Y, Hu W, Zheng Q, Cao J, Wu Y. Xie R, et al. Among authors: ma y. Front Pharmacol. 2023 Oct 19;14:1249632. doi: 10.3389/fphar.2023.1249632. eCollection 2023. Front Pharmacol. 2023. PMID: 37927608 Free PMC article.

6

GraphkmerDTA: integrating local sequence patterns and topological information for drug-target binding affinity prediction and applications in multi-target anti-Alzheimer's drug discovery.

Zhang Z, Luo G, Ma Y, Wu Z, Peng S, Chen S, Wu Y. Zhang Z, et al. Among authors: ma y. Mol Divers. 2025 Jan 10. doi: 10.1007/s11030-024-11065-7. Online ahead of print. Mol Divers. 2025. PMID: 39792322

7

Exploring PANoptosis in breast cancer based on scRNA-seq and bulk-seq.

He P, Ma Y, Wu Y, Zhou Q, Du H. He P, et al. Among authors: ma y. Front Endocrinol (Lausanne). 2023 Jun 28;14:1164930. doi: 10.3389/fendo.2023.1164930. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37455906 Free PMC article.

8

Mitochondrial DNA methylation is a predictor of immunotherapy response and prognosis in breast cancer: scRNA-seq and bulk-seq data insights.

Ma Y, Du J, Chen M, Gao N, Wang S, Mi Z, Wei X, Zhao J. Ma Y, et al. Front Immunol. 2023 Jun 29;14:1219652. doi: 10.3389/fimmu.2023.1219652. eCollection 2023. Front Immunol. 2023. PMID: 37457713 Free PMC article.

9

Gas-Phase Scattering of Transition Metal Atoms Fe, Ir, and Pt with CH₄, O₂, and CO₂.

Yan D, Ma Y, Liu J, Xu A, Song F, Zhou T, Yuan Z, Liu X, Wang F. Yan D, et al. Among authors: ma y. J Phys Chem A. 2025 Jan 17. doi: 10.1021/acs.jpca.4c06642. Online ahead of print. J Phys Chem A. 2025. PMID: 39823280

10

Chemical Constituents of the Deep-Sea-Derived Penicillium citrinum W22 and Their Ferroptosis Inhibitory Activity.

Zou ZB, Ma YL, Li Y, Nie SS, Li Y, Xie CL, Li LS, Yang XW. Zou ZB, et al. Among authors: ma yl. Chem Biodivers. 2025 Jan 17:e202403319. doi: 10.1002/cbdv.202403319. Online ahead of print. Chem Biodivers. 2025. PMID: 39823261

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

43,273 results

Search Page

Filters